What does CUSIP 44486Q103 represent in this 13F holders report?

CUSIP 44486Q103 is the security identifier for HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

How many institutions held HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share in Q1 2026?

156 institutional investors reported HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share for Q1 2026. Use the holders table for investor-level position and value details.

Humacyte, Inc. - Common Stock, par value $0.0001 per share (HUMA)

CUSIP: 44486Q103

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 58,856,823
Total 13F value: $35,722,631
Share change: +3,531,217
Put/Call ratio: 42%
SEC-reported price per share: $0.61
Number of holders: 156
Value change: +$725,386
Number of buys: 83
Number of sells: 46
Shares outstanding: 269,769,473

Security key

44486Q103

Report period

Q1 2026

Institutions

156

Top holders

HUMA full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Previous quarter: Q4 2025 Humacyte, Inc. SEC filings Humacyte, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 44486Q103

Newer quarter: Q2 2026 Previous quarter: Q4 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Fresenius Medical Care AG

Disclosed value leader

FRESENIUS MEDICAL CARE HO...

Comparable rows

15/15

Latest evidence

01 Jan 2026

13D/G 3/4/5 13F Lead comparable stake: 9.5% 13D/G row: Fresenius Medical Care AG Showing 1-6 of 15 holder rows.

Quick read

Fresenius Medical Care AG leads the comparable SEC ownership view at 9.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Fresenius Medical Care AG's linked filing trail.

Comparable ownership Top 5

Fresenius Medical Care AG 9.5%

FRESENIUS MEDICAL CARE HOLDINGS I... 6.8%

BlackRock, Inc. 4.2%

VANGUARD GROUP INC 3.1%

GEODE CAPITAL MANAGEMENT, LLC 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Fresenius Medical Care AG	13D/G Fresenius Medical Care Holdings, Inc. 13D/G	9.5%	— 18,312,735 shares	$0	01 Jan 2026
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/	3/4/5 Former 10% Shareholder 3/4/5	6.8%	$21,792,154 18,312,735 shares	—	26 Aug 2021
BlackRock, Inc.	13F Company 13F	4.2%	$10,896,986 11,345,119 shares	—	31 Dec 2025
VANGUARD GROUP INC	13F Company 13F	3.1%	$8,088,709 8,416,971 shares	—	31 Dec 2025
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	1.4%	$3,573,953 3,720,436 shares	—	31 Dec 2025
STATE STREET CORP	13F Company 13F	1.1%	$2,725,204 2,837,276 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

156

58,856,823

Rows available

156

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

146

Q1 2026 holders

156

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend